Robert L. Tychsen, MDMarch 11, 2022

FDA 483 - Robert L. Tychsen, MD - March 11, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Robert L. Tychsen, MD

Record Details

An FDA inspection of Robert L. Tychsen, MD, a clinical investigator in St Louis, MO, revealed significant deficiencies in the protection of human subjects. Observations included failures to obtain informed consent prior to study procedures and discrepancies in the documentation of consent. Additionally, subject case history records were found to be inaccurate or incomplete, with issues regarding original consent forms and participant identification.

Company: Robert L. Tychsen, MD
Inspection Date: March 11, 2022
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West II
Person: Karen M. Montgomery (issuing_officer)

Open in Dashboard

ID · 422df7c8-f1ff-4378-a59c-2f99915d91fa